Revolo Biotherapeutics

HQ
New Orleans, Louisiana, USA
25 Total Employees
Year Founded: 2011

Jobs at Similar Companies

Hybrid
McPherson, Kansas, United States
Hybrid
Delegación Cuajimalpa de Morelos, Mexico City, Mexico

Similar Companies Hiring

Pharmaceutical • Natural Language Processing • Machine Learning • Healthtech • Biotech • Artificial Intelligence
18 Offices
121990 Employees
Software • Pharmaceutical • Manufacturing • Healthtech • Biotech • Analytics
4 Offices
50000 Employees
Machine Learning • Design • Biotech • Artificial Intelligence
2 Offices
95 Employees
Revolo Biotherapeutics is developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases. Its two drug candidates, ‘1805 and ‘1104, a protein and a peptide respectively, reset the immune system by preventing the chronic pro-inflammatory immune response that results in autoimmune or allergic disease. ‘1805 is a modified analogue of a key molecule in immune function and is in clinical development for moderate-to-severe rheumatoid arthritis and non-infectious uveitis. ‘1104 is a peptide derived from a natural immune-regulatory protein and is in clinical development for patients with eosinophilic esophagitis (EoE) and allergic disease. The disease-agnostic mechanism of action of Revolo Biotherapeutic’s assets provides a potential platform for the development of treatments for multiple autoimmune and allergic diseases. Visit www.revolobio.com to learn more.

Revolo Biotherapeutics Offices

OnSite Workspace

Employees work from physical offices.

Typical time on-site: None
HQNew Orleans, Louisiana, USA